Lund Hemodynamic Lab
1 – 10 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Localization, Proteolytic Processing, and Binding Partners of Versican Isoforms in Vascular Lesions of Pulmonary Arterial Hypertension
2025) In The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society(
- Contribution to journal › Article
- 2024
-
Mark
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Plasma extracellular matrix and inflammatory proteins as biomarkers for diagnosis, differentiation, and risk assessment in pulmonary arterial hypertension - utilizing Lund Cardio Pulmonary Registry
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
(
- Contribution to journal › Article
-
Mark
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
(
- Contribution to journal › Scientific review
-
Mark
Left ventricular dysfunction in pulmonary arterial hypertension is attributed to underfilling rather than intrinsic myocardial disease : a CMR 2D phase contrast study
(
- Contribution to journal › Article
-
Mark
Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Letter
-
Mark
Risk stratification and treatment goals in pulmonary arterial hypertension
(
- Contribution to journal › Scientific review
-
Mark
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
(
- Contribution to journal › Article
-
Mark
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation : The Results of a Randomized Controlled Trial (SCHEDULE Trial)
(
- Contribution to journal › Article